Efficient Consecutive Alkylation-Knoevenagel Functionalisations in Formyl Aza-Heterocycles Using Supported Organic Bases

Abstract

An efficient solution-phase parallel procedure to perform the structural diversification of some formyl aza-heterocycles employing supported organic bases (PS-BEMP, PS-TBD or Si-TBD) is described. The library synthesis is based on a consecutive alkylation-Knoevenagel functionalisation that employs alkyl halides, Michael acceptors, and malonic acid derivatives as diversity elements.

supported bases - catalysis - consecutive functionalisations - Knoevenagel condensation - Michael addition

References and Notes

<A NAME="RD24206ST-1">1</A> Zaragoza F. Dörwald X. Organic Synthesis on Solid Phase   Vol. 2:  Wiley-VCH; Weinheim: 2002. 

<A NAME="RD24206ST-2A">2a</A> Boger DL. Desharnais J. Capps K. Angew. Chem. Int. Ed.  2003,  42:  4138 

<A NAME="RD24206ST-2B">2b</A> An H. Dan Cook P. Chem. Rev.  2000,  100:  3311 

<A NAME="RD24206ST-2C">2c</A> Nefzi A. Ostresch JM. Houghten RA. Chem. Rev.  1997,  97:  449 

<A NAME="RD24206ST-3A">3a</A> Kirschning A. Monenschein A. Wittemberg R. Angew. Chem. Int. Ed.  2001,  40:  650 

<A NAME="RD24206ST-3B">3b</A> Ley SV. Baxendale IR. Bream RN. Jackson PS. Leach AG. Longbottom DA. Nesi M. Scott JS. Storer RI. Taylor SJ. J. Chem. Soc., Perkin Trans. 1  2000,  3815 

<A NAME="RD24206ST-4">4</A> Collins I. J. Chem. Soc., Perkin Trans. 1  2000,  2845 

<A NAME="RD24206ST-5">5</A>

Relative base strength of supported bases used in this study; the pKa values reported for the conjugated acids of their corresponding non-supported analogues are: TBD: 25.44 (MeCN, 25 °C), BEMP: 27.63 (MeCN, 25 °C); see ref. 6a. Supported reagents employed in this work were purchased from Fluka (PS-BEMP), Argonaut (PS-TBD) and Silicycle (Si-TBD).

<A NAME="RD24206ST-6A">6a</A> Schwesinger R. Willaredt J. Schemper H. Keller M. Schmitt D. Fritz H. Chem. Ber.  1994,  127:  2435 

<A NAME="RD24206ST-6B">6b</A> Bensa D. Constantieux T. Rodriguez J. Synthesis  2004,  923 

<A NAME="RD24206ST-6C">6c</A> Graybill TL. Thomas S. Wang MA. Tetrahedron Lett.  2002,  43:  5305 

<A NAME="RD24206ST-6D">6d</A> Adams G. Tetrahedron Lett.  2003,  44:  5041 

<A NAME="RD24206ST-7A">7a</A> Alhambra C. Castro J. Chiara JL. Fernández E. Fernández Mayorales A. Fiandos JM. García-Ochoa S. Martín Ortega MD. Tetrahedron Lett.  2001,  42:  6675 

<A NAME="RD24206ST-7B">7b</A> Xu W. Mohan R. Morrissey M. Bioorg. Med. Chem. Lett.  1998,  8:  1089 

<A NAME="RD24206ST-7C">7c</A> Ley SV. Massi A. J. Chem. Soc., Perkin Trans. 1  2000,  3645 

<A NAME="RD24206ST-7D">7d</A> Caldarelli M. Habermann J. Ley SV. J. Chem. Soc., Perkin Trans. 1  1999,  107 

<A NAME="RD24206ST-7E">7e</A> Baxendale IR. Ley SV. Bioorg. Med. Chem. Lett.  2000,  10:  1983 

<A NAME="RD24206ST-7F">7f</A> McComas W. Chen L. Kim K. Tetrahedron Lett.  2000,  41:  3573 

<A NAME="RD24206ST-7G">7g</A> Schwesinger R. Nachr. Chem., Tech. Lab.  1990,  38:  1214 

<A NAME="RD24206ST-8A">8a</A> Subba Rao YV. De Vos DE. Jacobs PA. Angew. Chem., Int. Ed. Engl.  1997,  36:  2261 

<A NAME="RD24206ST-8B">8b</A> Fringuelli F. Pizzo F. Vittoriani C. Vaccaro L. Chem. Commun.  2004,  2756 

<A NAME="RD24206ST-8C">8c</A> Xu W. Mohan R. Morrissey M. Tetrahedron Lett.  1997,  38:  7337 

<A NAME="RD24206ST-8D">8d</A> Organ MG. Dixon CE. Biotechnol. Bioeng. Comb. Chem.  2000,  71:  71 

<A NAME="RD24206ST-8E">8e</A> Iijima K. Fukuda W. Tomoi M. J. Macromol. Sc., Part A: Pure Appl. Chem.  1992,  29:  249 

<A NAME="RD24206ST-8F">8f</A> Tamura Y. Fukuda W. Tomoi M. Synth. Commun.  1994,  24:  2907 

<A NAME="RD24206ST-8G">8g</A> Boisnard S. Chastanet J. Zhu J. Tetrahedron Lett.  1999,  7469 

<A NAME="RD24206ST-8H">8h</A> Chiara JL. Encinas L. Díaz B. Tetrahedron Lett.  2005,  46:  2445 

<A NAME="RD24206ST-9">9</A> Ye W. Xu J. Tan C.-T. Tan C.-H. Tetrahedron Lett.  2005,  46:  6875 

<A NAME="RD24206ST-10A">10a</A> Smith JT. Zeiler HJ. History and Introduction In Handbook of Experimental Pharmacology   Vol. 127:  Springer; Berlin: 1998.  p.1-11 

<A NAME="RD24206ST-10B">10b</A> Pharmaceutical Substances: Synthesis, Patents, Applications   Kleemann A. Engel J. Thieme; Stuttgart: 2001. 

<A NAME="RD24206ST-10C">10c</A> Riesbeck K. J. Chemother.  2002,  14:  3 

<A NAME="RD24206ST-10D">10d</A> Milata V. Claramunt R. Elguero J. Zalupski P. Targets Heterocycl. Syst.  2000,  4:  167 

<A NAME="RD24206ST-10E">10e</A> Brown EM. Reeves DS. Antibiot. Chemother.  1997,  419 

<A NAME="RD24206ST-10F">10f</A> Hirai K. Nippon Kagaku Ruoho Gakkai Zusshi  2005,  53:  349 

<A NAME="RD24206ST-10G">10g</A> Horton DA. Bourne GT. Smythe ML. Chem. Rev.  2003,  103:  893 

<A NAME="RD24206ST-11">11</A> Sotelo E. Fraiz N. Yáñez M. Laguna R. Cano E. Brea J. Raviña E. Bioorg. Med. Chem. Lett.  2002,  12:  1575 

<A NAME="RD24206ST-12">12</A> Amaresh RR. Perumal PT. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.  1997,  36:  541 

For publications related to the catalysis of Knoevenagel reaction by supported reagents, see:

<A NAME="RD24206ST-13A">13a</A> Isobe K. Hoshi T. Suzuki T. Hagiwara H. Mol. Divers.  2005,  9:  317 

<A NAME="RD24206ST-13B">13b</A> Zeng R. Fu X. Gong C. Sui Y. Ma X. Yang X. J. Mol. Catal. A: Chem.  2005,  229:  1 ; and references cited therein

<A NAME="RD24206ST-13C">13c</A> Strohmeier GA. Kappe CO. Angew. Chem. Int. Ed.  2004,  43:  621 

<A NAME="RD24206ST-14A">14a</A> Hadjeri M. Mariotte AM. Boomendjel A. Chem. Pharm. Bull.  2001,  49:  1352 

<A NAME="RD24206ST-14B">14b</A> Baket D. Sasaki H. Kinoshita T. Tsutsumi H. Sakane K. Bull. Chem. Soc. Jpn.  1996,  69:  1371 

<A NAME="RD24206ST-15">15</A> Brown DJ. In The Pyridazines I, Chemistry of Heterocyclic Compounds   Taylor EC. Wipf P. Wiley; New York: 2000.  p.56 

<A NAME="RD24206ST-16">16</A> Sundberg RJ. Indoles   Academic Press; London: 1996. 

<A NAME="RD24206ST-17A">17a</A>

www.silicycle.com.

<A NAME="RD24206ST-17B">17b</A>

www.sigma-aldrich.com.

For publications related to the aza-Michael reaction by supported reagents, see:

<A NAME="RD24206ST-18A">18a</A> Fetterly BM. Jana NK. Verkade JG. Tetrahedron  2006,  62:  440 

<A NAME="RD24206ST-18B">18b</A> Bartoli G. Bartolacci M. Giuliani A. Marcantoni E. Massaccessi M. Torregiani E. J. Org. Chem.  2005,  70:  169 

<A NAME="RD24206ST-19">19</A>

Representative Procedure for the Alkylation-Knoevenagel (Method A) or Aza-Michael-Knoevenagel (Method B) Sequences: In a coated Kimble vial was charged a mixture of the scaffold A1-A3 (0.60 mmol) in the appropriate solvent [THF (3 mL) for A1 or A3, toluene for A2]. The supported organic base (1.5 mmol of PS-TBD 2 for method A, 0.12 mmol for method B) and the alkyl halide (0.66 mmol; method A) or the Michael acceptor (0.72 mmol; method B) were added at the appropriate temperature (40 °C for A1 and A3, r.t. for A2 in method A, 60 °C for all scaffolds in method B). The sample was vortexed for 30 min to give the corresponding N-blocked adduct. Addition of the appropriate malonic acid derivative (1.1 equiv, stirring for 4-14 h; see Figure [4] ) to the adduct at the appropriate temperature (40 °C for A1, 60 °C for A2, r.t. for A3 in method A; 50 °C, 60 °C and r.t. for A1, A2 and A3, respectively in method B) in the corresponding solvent, led to the Knoevenagel product after simple filtration of the supported reagents by a fritted syringe. Evaporation of the solvent and purification by a parallel short chromatographic filtration (on silica gel) employing a vacuum manifold (Visiprep®) to remove the small excess of malonic acid derivative afforded pure samples that were characterised by spectroscopic and analytical data.

<A NAME="RD24206ST-20">20</A>

Complete details of the synthesis and spectral characteristics of the compounds obtained will be published elsewhere in a full paper. All compounds gave satisfactory spectral data (¹H NMR, ¹³C NMR, FTIR, MS). Yields given correspond to the isolated pure compounds. Chromatographic filtration for all compounds was carried out using EtOAc-hexane (1:4) as eluent mixture. Selected physical and spectral data for some compounds are as follows: A1B4D3: mp 218-219 °C (i-PrOH); yield: 70%. IR (KBr): 2233 (CN), 1709 (CO), 1665 (CO), 1599 (Ar) cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 9.12 (s, 1 H, CH), 8.88 (s, 1 H, CH), 8.47 (d, J = 8.2 Hz, 1 H, Ar), 7.50-7.64 (m, 1 H, Ar), 7.33-7.43 (m, 4 H, Ar), 7.19-7.23 (m, 3 H, Ar), 5.42 (s, 2 H, CH₂), 4.34 (q, J = 7.2 Hz, 2 H, CH₂), 1.35 (t, J = 7.2 Hz, 3 H, CH₃). MS (70 eV): m/z (%) = 358 (11) [M⁺], 285 (100), 91 (16). HRMS: m/z [M⁺] calcd for C₂₂H₁₈N₂O₃: 358.1317; found: 358.1316. A2B4D3: mp 130-131 °C (i-PrOH); yield: 67%. IR (KBr): 2209 (CN), 1747 (CO), 1578 (Ar), 1094 (COC) cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 8.61 (s, 1 H, CH), 8.60 (s, 1 H, CH), 7.83-7.86 (m, 1 H, Ar), 7.27-7.35 (m, 6 H, Ar), 7.15-7.18 (m, 2 H, Ar), 5.41 (s, 2 H, CH₂), 4.37 (q, J = 7.1 Hz, 2 H, CH₂), 1.39 (t, J = 7.1 Hz, 3 H, CH₃). MS (70 eV): m/z (%) = 330 (75) [M⁺], 183 (1), 139 (2), 91 (100). A3B1D2: mp 220-221 °C (i-PrOH); yield: 79%. IR (KBr): 2229 (CN), 1727 (CO), 1659 (CO), 1580 (Ar), 1083 (COC) cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 7.92 (s, 1 H, CH), 7.44-7.53 (m, 4 H, Ar + CH), 7.35-7.39 (m, 2 H, Ar), 3.92 (s, 3 H, CH₃), 3.89 (s, 3 H, CH₃). MS (70 eV): m/z (%) = 295 (100) [M⁺], 236 (100), 208 (35), 164 (30). HRMS: m/z [M⁺] calcd for C₁₆H₁₃N₃O₃: 295.0957; found: 295.0955. A1C4D2: mp 186-187 °C (i-PrOH); yield: 70%. IR (KBr): 2220 (CN), 1717 (CO), 1624 (CO), 1584 (Ar), 1093 (COC) cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 9.10 (s, 1 H, CH), 8.81 (s, 1 H, CH), 8.47 (d, J = 8.2 Hz, 1 H, Ar), 7.70-7.74 (m, 1 H, Ar), 7.45-7.48 (m, 2 H, Ar), 4.54 (t, J = 6.7 Hz, 2 H, CH₂), 4.15 (q, J = 7.2 Hz, 2 H, CH₂), 3.86 (s, 3 H, CH₃), 2.91 (t, J = 6.7 Hz, 2 H, CH₂), 1.20 (t, J = 7.2 Hz, 3 H, CH₃). MS (70 eV): m/z (%) = 354 (16) [M⁺], 323 (4), 295 (100), 267 (16). A2C1D3: mp 153-154 °C (i-PrOH); yield: 80%. IR (KBr): 2215 (CN), 1721 (CO), 1589 (Ar), 1039 (COC) cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 8.55 (s, 1 H, CH), 8.54 (s, 1 H, CH), 7.86 (dd, J = 1.6, 5.1 Hz, 1 H, Ar), 7.35-7.45 (m, 3 H, Ar), 4.57 (t, J = 6.9 Hz, 2 H, CH₂), 4.37 (q, J = 7.1 Hz, 2 H, CH₂), 2.94 (t, J = 6.9 Hz, 2 H, CH₂), 1.35 (t, J = 7.1 Hz, 3 H, CH₃). MS (70 eV): m/z (%) = 293 (100) [M⁺], 253 (64), 225 (26), 179 (9). A3C2D1: mp 127-128 °C (i-PrOH); yield: 65%. IR (KBr): 2235 (CN), 1736 (COO), 1670 (CO), 1588 (Ar), 1092 (COC) cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 7.51-7.55 (m, 5 H, Ar), 7.47 (s, 1 H, CH), 7.34 (s, 1 H, CH), 4.38 (t, J = 6.9 Hz, 2 H, CH₂), 3.67 (s, 3 H, CH₃), 2.90 (t, J = 6.9 Hz, 2 H, CH₂). MS (70 eV): m/z (%) = 334 (22) [M⁺], 303 (16), 275 (26), 247 (50), 234 (100), 222 (25), 191 (23).